CONSORTIUM MAKING ‘SIGNIFICANT PROGRESS’ ON ANTIBODY TEST11 Jun 2020 15:36
11 Jun 2020 Wales Manufacturing
BBI Solutions has hailed the ‘significant progress’ made by the UK-Rapid Test Consortium (UK-RTC) to develop a Covid-19 lateral flow antibody test.
Seven weeks ago, the UK Government commissioned the UK-RTC – of which BBI is a part – to develop a test that can be used by people in their homes.
The UK-RTC says it has made progress in both developing the antibody test, as well as progress with the regulatory and logistics challenges needed to be able to deploy the test directly with individuals across the UK.
The consortium has reported that it is now consistently picking up positive samples across the range, including weak positives, while ensuring negative samples are not detected.
Later this month, the UK-RTC expects to reach design freeze – a binding decision among the consortium partners - which will allow it to move onto scale up, verification and validation activities, prior to the test being made available for manufacture.
In parallel with the above activities, the consortium is working with the UK Government and regulatory authorities to ensure proper approval of the test as quickly as possible.
Crumlin-based BBI Solutions is playing a key role as a consortium partner in the UK-RTC work, specifically in terms of leading on the development of the app, and providing critical reagents for the test.
BBI Group chief executive Dr Mario Gualano said: "This is a very complex project that is being completed at extraordinary speed, compared to a normal test development programme.
"But we remain on track to deliver a test to the UK that will make a significant difference to the approach needed to manage COVID-19 infections."
https://www.insidermedia.com/news/wales/consortium-making-significant-progress-on-antibody-test
Sign In
Follow the stocks
